Ara
Toplam kayıt 4, listelenen: 1-4
Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome
(Comenius University, 2018)
INTRODUCTION: In this study, our aim was to evaluate clinical utilities of Pentraxin 3 (PTX3) and Ischemiamodified Albumin (IMA) in diagnosis of acute coronary syndrome (ACS) and compare these two biomarkers with a ...
Association of prediabetes with higher coronary atherosclerotic burden among patients with first diagnosed acute coronary syndrome
(SAGE Publications Inc., 2019)
Diabetes mellitus (DM) is associated with more extensive coronary atherosclerosis and more vulnerable plaque phenotypes. However, DM should not be considered a homogeneous and purely binary entity in terms of risk assessment. ...
Role of ischemia-modified albumin in clinical practice
(Walter de Gruyter GmbH, 2015)
Difficulty in establishing a diagnosis of acute coronary syndrome (ACS) in the clinical setting has led researchers to investigate novel markers that show increased blood levels before the myocardial necrosis occurs. In ...
Advantages and pitfalls of the glycated hemoglobin A1c measurement in acute coronary syndrome: Start simple, evolve to more sophisticated
(SAGE Publications Inc., 2019)
We would like to thank Cetin et al1 for their interest in our work titled, “Association of Prediabetes With Higher Coronary Atherosclerotic Burden Among Patients With First Diagnosed Acute Coronary Syndrome”2 about the ...